Rhinosinusitis: Developing guidance for clinical trials
書誌事項
- 公開日
- 2006-11
- 権利情報
-
- https://www.elsevier.com/tdm/userlicense/1.0/
- https://www.elsevier.com/legal/tdmrep-license
- DOI
-
- 10.1016/j.jaci.2006.09.005
- 10.1016/j.otohns.2006.09.014
- 公開者
- Elsevier BV
この論文をさがす
説明
<jats:p>The Rhinosinusitis Initiative was developed by 5 national societies. The current guidance document is an expansion of the 2004 publication, “Rhinosinusitis: Establishing definitions for clinical research and patient care” and provides templates for clinical trials in antimicrobial, anti‐inflammatory, and symptom‐relieving therapies for the following: (1) acute presumed bacterial rhinosinusitis, (2) chronic rhinosinusitis (CRS) without nasal polyps, (3) CRS with nasal polyps, and (4) classic allergic fungal rhinosinusitis. In addition to the templates for clinical trials and proposed study designs, the Rhinosinusitis Initiative has developed 6 appendices, which address (1) health outcomes, (2) nasal endoscopy and staging of CRS, (3) radiologic imaging, (4) microbiology, (5) laboratory measures, and (6) biostatistical methods.</jats:p>
収録刊行物
-
- Journal of Allergy and Clinical Immunology
-
Journal of Allergy and Clinical Immunology 118 (5), S17-S61, 2006-11
Elsevier BV
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1362262946077166208
-
- ISSN
- 10976817
- 00916749
- 01945998
-
- Web Site
- https://api.elsevier.com/content/article/PII:S0091674906019075?httpAccept=text/xml
- https://api.elsevier.com/content/article/PII:S0091674906019075?httpAccept=text/plain
- https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.otohns.2006.09.014
- https://aao-hnsfjournals.onlinelibrary.wiley.com/doi/pdf/10.1016/j.otohns.2006.09.014
-
- データソース種別
-
- Crossref
- OpenAIRE